Project Grant R01AI194527
- Federal Project Grant Summary Tufts University School of Medicine received a $227,640 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 30, 2026, with a completion date of March 29, 2029. The grant supports investigator-initiated biomedical research focused on elucidating the molecular mechanisms of amidase (CWLD) activity regulation during spore development in...
- Federal Grant Award Summary Tufts University School of Medicine received a $136,104 Project Grant award dated October 24, 2025, from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant funds investigator-initiated research examining how the spatial distribution and epithelial association of Clostridioides difficile bacteria, combined with heterogeneous toxin gene expression, influence disease...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Tufts University School of Medicine a Project Grant of $453,750 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support investigator-initiated biomedical research. The award, effective February 2, 2026 through January 31, 2028, funds research examining how the bacterium Shigella flexneri evades the host immune response by suppressing pyroptosis—a critical...
- Federal Project Grant Award Summary Tufts University School of Medicine received a $3.18M Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 26, 2025, with completion expected July 31, 2029. The award funds investigation of Yop effector protein activities in Microfold (M) cells during murine infection with Yersinia pseudotuberculosis (YPTB). The research utilizes a...
- Federal Project Grant Award Summary The University of Massachusetts Medical School received a $773,706 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded June 11, 2026, with a completion date of May 31, 2031. This award funds biomedical research investigating the regulation of programmed cell death through protein succination, a post-translational modification process mediated by...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Tufts University School of Medicine a $412,377 Project Grant on September 10, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop and optimize in vitro cultivation systems for Enterocytozoon bieneusi (EB), a clinically significant opportunistic microsporidian fungus responsible for persistent diarrhea and wasting in immunocompromised populations,...
- Federal Project Grant Award Summary Tufts University School of Medicine received a $156,080 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on January 29, 2026, with completion targeted for August 15, 2028. The grant funds research investigating the spatio-temporal modulation of innate immune cell responses to Mycobacterium tuberculosis (MTB) infection, specifically examining...
- Federal Project Grant Award Summary Tufts University School of Medicine received a $151,040 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded January 1, 2026, with completion targeted for August 31, 2028. The award supports research to identify and characterize the unique cell division machinery (divisome) of Clostridioides difficile, a major nosocomial pathogen. The research...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $251,250 Project Grant to the University of Massachusetts Medical School under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective April 1, 2026, through March 31, 2028. This exploratory R21 grant funds biomedical research investigating the role of the SLC46A3 transporter protein in facilitating muramyl dipeptide (MDP) transport and subsequent NOD2...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Tufts University School of Medicine a $450,630 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) for a two-year project period from August 1, 2025, through July 31, 2027. The award funds spatiotemporal investigation of interactions between pneumolysin, pulmonary epithelium, and polymorphonuclear leucocytes (PMNs/neutrophils) that contribute to...
This project grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports investigative research into the complex nonlinear dynamics governing tuft cell-microbiome interactions and their role in immune regulation. The University of Massachusetts Medical School received $836,691 in obligated funding (awarded June 17, 2026, with completion anticipated by May 30, 2031) to conduct mathematical modeling and experimental validation studies examining how feedback loops between tuft cells, intestinal microbiota, and immune cells collectively optimize intestinal homeostasis and resilience. The research specifically investigates how tuft cells sense succinate—a microbial metabolite produced by succinate-producing bacteria—and respond by secreting interleukin-25 to activate type 2 lymphocytes, creating a self-reinforcing feedback mechanism that protects against pathogen-induced colitis while preventing uncontrolled inflammation. The project combines computational modeling with laboratory-based experimental research to elucidate how epithelial-immune-microbiome interactions form coordinated feedback loops that enable the intestinal system to flexibly transition between homeostatic and hyperplastic states. The research examines how tuft cells actively promote colonization by beneficial microbes while other epithelial cell types such as goblet cells and Paneth cells may exert complementary or counterbalancing influences. The project's outcomes will advance understanding of intestinal mucosal immunology and may inform therapeutic approaches to infectious diseases, inflammatory conditions, and immune-mediated disorders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $836.7k | 6/17/26 |